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A B S T R A C T
Human induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs) have been shown to be useful to
improve techniques that are developed for the study of cardiac disease. Abnormalities in Ca2+ transients are
commonly present in iPSC-CMs derived from individuals with a cardiac disease. We previously observed that
Ca2+ transient signals of healthy CMs can be distinguished from transients of CMs derived from individuals
having diﬀerent genetic cardiac diseases. Machine learning was used to distinguish diﬀerent diseases from each
other as well as from controls. We wanted further to investigate whether we are able to separate iPSC-CM Ca2+
signals of any genetic cardiac disease as one group from those of healthy individuals by utilizing machine
learning methods. A total number of 593 CM transient signals from healthy individuals and from patients were
analyzed. We obtained a best classiﬁcation accuracy of 87% between the disease group and controls. This ﬁnding
provides evidence that machine learning methods are eﬃcient for identifying iPSC-CMs derived from individuals
with a disease phenotype, and that iPSC-CMs may be useful to identify individuals at risk for a cardiac event.
1. Introduction
Genetic cardiac diseases present a wide range of symptoms, ranging
from completely asymptomatic to severe arrhythmias, and even sudden
cardiac death [1,2]. Additionally, most if not all of these diseases have
an increased risk for arrhythmia, in addition to structural or other
cardiac abnormality, e.g., in various cardiomyopathies. If the mutation
causing disease is known in the family, it is easy to focus on the mu-
tation carriers for follow-up and primary prevention of potential ar-
rhythmias. However, this is often problematic when the disease is
presented by sudden death in the family, but no mutations are found. In
such situations, induced pluripotent stem cell (iPSC) -derived cardio-
myocytes may provide a useful alternative to predict arrhythmic risk,
and to identify those family members with increased risk of clinical
symptoms including arrhythmias.
On a cellular level, cardiac functionality can be studied with the
help of CMs diﬀerentiated from human pluripotent stem cells [3,4]. The
induced pluripotent stem cell (iPSC) technology oﬀers a way to repro-
gram diﬀerentiated cells back to the pluripotent state – and, therefore,
it is a useful tool for studying the pathophysiology of various disorders
and drug responses in human cells [5]. Additionally, cellular diﬀer-
entiation and maturation can be studied with these cells [6].
Thus far, iPSC-CMs have successfully been used to model genetic
cardiac diseases such as catecholaminergic polymorphic ventricular
tachycardia (CPVT) [3,4,7–12], long QT syndrome (LQT) [13–16] and
hypertrophic cardiomyopathy (HCM) [17–19]. iPSC-derived CMs have
revealed considerable abnormalities and diversity in intracellular Ca2+
cycling features compared to healthy control CMs. Ca2+ cycling plays
an important role in cardiac functionality by linking electrical activa-
tion and contraction, and the characterization of Ca2+ cycling is vital in
order to facilitate investigations of cardiac disorders and dysfunctions,
as well as to study disease management with diﬀerent compounds.
Heretofore, machine learning has rarely been applied to the data
associated with induced pluripotent stem cell-derived cardiomyocytes.
Machine learning has however been applied to the mechanistic action
of cardioactive drugs [20]. We demonstrated in previous articles that
the separation of calcium transient signals of abnormally and normally
grown cardiomyocytes can be accurately done with machine learning
[21,22]. In these papers, abnormality is deﬁned as deformed Ca2+ peak
forms varying in amplitudes (sizes) and durations of Ca2+ transients
and normality as harmonious transients of approximately the same size
and form throughout entire calcium transient signals. To the best of our
knowledge, our recent study [23] was the ﬁrst one in which diﬀerent
genetic cardiac diseases were separated according to their calcium
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transient signals by using classiﬁcation performed with machine
learning methods.
In the present research, visually normal and abnormal Ca2+ tran-
sient signals and peak variables of three genetic cardiac diseases and
healthy control CMs were used. Disease-speciﬁc CMs were generated
from patients suﬀering from CPVT, an exercise-induced malignant ar-
rhythmogenic disorder [3,8], LQT type 1, an electric disorder of the
heart that predisposes patients to arrhythmias, and HCM, a disorder
that aﬀects the structure of heart muscle tissue leading to arrhythmias
and progressive heart failure [19]. All of the transients of diseased cells
were pooled and compared to all of the transients obtained from control
cells, and diﬀerent machine learning algorithms were designed and
used to analyze this technology to automatically distinguish the groups.
2. Materials
The current study was approved by the Ethics Committee of
Pirkanmaa Hospital District in establishing, culturing and diﬀer-
entiating human iPSC lines (R08070). The patient-speciﬁc iPSC lines
were established and characterized as described earlier, as well as the
CM diﬀerentiation and dissociation of beating areas [22]. The studied
cell lines included six CPVT lines generated from CPVT patients car-
rying cardiac ryanodine receptor (RyR2) mutations, four HCM cell lines
generated from HCM patients carrying either α-tropomyosin (TPM1) or
myosin-binding protein C (MYBPC3) mutations, two LQT type 1 cell
lines generated from patients carrying potassium voltage-gated channel
subfamily Q member 1 (KCNQ1) mutations, and one cell line generated
from a healthy control individual. Thus, there were 13 subjects alto-
gether.
Ca2+ imaging was conducted in spontaneously beating, 4 μM Fura-2
AM (Invitrogen, Molecular Probes) or 4 μM Fluo-4 AM (Life
Technologies Ltd) loaded dissociated CMs as described earlier [3].
During the measurements, CMs were perfused with 37 °C HEPES based
perfusate consisting of (in mM) 137 NaCl, 5 KCl, 0.44 KH2PO4, 20
HEPES, 4.2 NaHCO3, 5 D-glucose, 2 CaCl2, 1.2 MgCl2, and 1 Na-pyr-
uvate (the pH was adjusted to 7.4 with NaOH). Ca2+ measurements
were conducted on an inverted IX70 microscope with a UApo/340 x20
air objective (both Olympus Corporation, Hamburg, Germany) or with
Axio Observer.A1 microscope with Objective Fluar 20x/0.75 M27 (both
Carl Zeiss Microscopy GmbH, Göttingen, Germany). Images were taken
with an ANDOR iXon 885 CCD camera (Andor Technology, Belfast,
Northern Ireland) and synchronized with a Polychrome V light source
by a real time DSP control unit or with Lambda DG-4 Plus (Sutter In-
strument, California, USA) wavelength switcher and TILLvisION, Live
Acquisition (TILL Photonics, Munich, Germany) or ZEN 2 blue edition
software (Carl Zeiss Microscopy GmbH, Göttingen, Germany) software.
For Ca2+ analysis, regions of interest were selected for spontaneously
beating cells and background noise was subtracted before further pro-
cessing. Each Ca2+ signal corresponded to a recording from one cell.
3. Data computed from Ca2+ transient signals
Human induced pluripotent stem cell-derived CMs were the data
source from which cycling Ca2+ transient signals were obtained. Data
used in the computation were based on the peaks of Ca2+ transient
signals. Cycling peaks were recognized, and data variables or features
were extracted from every peak. Previously Ca2+ transient signals were
categorized using our recognition algorithm [22], which classiﬁed them
into either normal type or abnormal signal type on the basis of normal
or abnormal peaks of the signals, and where we observed that it was
possible to separate normal from abnormal signals up to the accuracy of
approximately 90% when compared to a human expert's classiﬁcation
decisions.
Fig. 1 presents 10 s segments of four signals as examples. The signals
were short, their durations being from 7.7 s to 46.5 s and 19.0 s on
average. An entire signal was determined to be abnormal if even a
single peak was observed as abnormal. In the current research, we did
not diﬀer normal and abnormal signals from each other, but advanced
to separate Ca2+ transient signals of diseased induced pluripotent stem
cell-derived CMs from those of control subjects. It was interesting to
study whether disease transient signals can be diﬀerentiated from those
of controls, although both classes contained both normal and abnormal
signals. The number of the abnormal control signals was only 12.6% of
all control signals. The disease transient signals originated from the
group of the three above-mentioned diseases: LQT1, HCM and CPVT.
These were used jointly as the disease class. The other class was formed
by the signals of the controls (wild type, WT).
The data used comprised 394 disease transient signals and 199
control transient signals. These contained, respectively, 179 normal and
215 abnormal signals, and 174 normal and 25 abnormal signals. It is
noticeable that there were only relatively few abnormal signals in
controls, since these were far more infrequent compared to those of
disease CMs.
Sampling of the transient signals contained three diﬀerent fre-
quencies, because the data were recorded at diﬀerent times and the
sampling frequency was increased in the meantime. The approximate
sampling frequencies were 8 Hz, 11 Hz and 23 Hz. In this order, 35%,
26% and 39% of the diseased signals were recorded, and, correspond-
ingly, 5%, 15% and 80% of the control signals.
In order to detect individual peaks of a transient signal, values of its
ﬁrst derivative were computed in short sequential segments, where
slopes of linear regression computed with sequential signal segments of
a few samples were used to estimate ﬁrst derivative values (Fig. 2). To
determine the beginning of a peak, its ﬁrst derivative values had to
remain smaller than a small positive threshold value determined ex-
perimentally during a few sequential slope values. Thereafter, slope
values became greater while proceeding forward along a typically steep
left side of a peak producing large positive ﬁrst derivative slope values.
Next a peak maximum or top was found when slope values again de-
creased less than the positive threshold value. After the maximum, ﬁrst
derivative slope values changed negative along the decreasing right
side of a peak (Fig. 2). Ultimately, the end of a peak was encountered
when the ﬁrst derivative slope values again increased close to zero. The
detailed procedure for the peak detection was introduced in our pre-
vious research [22]. However, oscillations of very small amplitudes
were not accepted as valid peaks in a signal, as follows. After the re-
moval of a possible linear trend in a signal, the amplitude of large peaks
in a signal was estimated as a diﬀerence from the average of the highest
sample (amplitude) values (15% of all) to the lowest sample values in
the current signal. Such peak candidates that had the amplitude of the
left or right side of a peak less than approximately 8% from the above
amplitude estimate of the large peaks were not accepted as peaks, but
were suspected as being probable noise [22]. The numbers of the peaks
extracted from the signals varied from 1 to 61, and were only 12.8 on
average.
After the recognition of the peaks from the transient signals, values
of 12 variables for every peak were computed as follows. First, the
amplitudes of the left and right side of a peak were computed - see
Fig. 2. Second, the durations of both peak sides were computed from
locations a to c and from c to e. Third, the maximum of the ﬁrst deri-
vative from the left side of a peak and the absolute minimum of the ﬁrst
derivative from the right side were computed. Fourth, the maximum
and absolute minimum of the second derivative were computed from
the right side only. The left side was not now applied, because fre-
quently these were too short (as to the number of samples) for second
derivative values to have been calculated. Fifth, the surface determined
by a peak curve and a line from the beginning to the end of a peak was
computed. Sixth, the duration (time diﬀerence) from the maximum at
location c to the maximum of the preceding peak was computed, or if
the current peak was the ﬁrst peak of a signal, the duration was cal-
culated from the signal beginning. Seventh, the duration (time diﬀer-
ence) from peak beginning a to location b of the ﬁrst derivative
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maximum of the left peak side and the duration from location c of the
peak maximum to location d of the ﬁrst derivative minimum of the right
peak side were computed.
To visualize the data, in other words, variable values computed
from 5290 recognized peaks of the disease transient signals and 2291
peaks of the control transient signals, after the normalization of the
data Stochastic Neighbor Embedding algorithm with the Euclidean
distance measure in MATLAB was used to present the data in two di-
mensions. This is depicted in Fig. 3. When a great part of the cases in
two diﬀerent classes are apart from each other, it is possible that this
predicts a successful classiﬁcation for the classes.
The means and standard deviations of all 12 variables are presented
in Table 1. Considerable diﬀerences for the means of two classes for
every variable are seen, which may denote a favorable classiﬁcation
chance between the disease and control transient signals.
Next we evaluated how eﬃcient the 12 variables are to separate or
classify the two classes. We ran the reliefF algorithm in MATLAB for our
data. It functions on the basis of applying a nearest neighbor searching
method, in order to measure the diﬀerentiation power or weight,
variable by variable. We chose nine k values for the numbers of nearest
neighbors, control parameter of the algorithm. They were 3, 5, 7, 9, 11,
15, 21, 25 and 31, where odd values only were used to prevent possible
ties (equal numbers from the two opposite classes) during nearest
neighbor searching. For each peak variable, the median of weights
given by the reliefF algorithm for results of nine runs (Fig. 4) was
computed. The positive weights mean that all variables are able to se-
parate the two classes. Weights are relative and they express ranking of
variables for diﬀerentiation of classes. For all nine runs, variables 3, 4, 5
Fig. 1. (a) A 10 s segment of a normal CPVT signal in which the peaks recognized to be normal are marked with green bars, and also the beginning and end of every
peak marked. (b) An abnormal CPVT signal in which all peaks were recognized as deformed to be abnormal and marked with stars. (c) A 10 s segment of a normal
control transient signal. (d) An abnormal control transient signal, where two abnormal peaks were marked with stars. (For interpretation of the references to colour in
this ﬁgure legend, the reader is referred to the Web version of this article.)
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and 11 obtained the greatest or best weights and variables 9, 10 and 12
resulted in the smallest or poorest instances to separate the two classes.
Instead, variables 1, 2, 6, 7 and 8 were between the best and poorest,
and their ranking varied slightly among the nine test runs, when their
Fig. 2. The peak is the ﬁrst one from the signal in
Fig. 1(a). The short red lines visualize imaginary
slopes (upward is positive, downward negative and
horizontal zero slope value) of the ﬁrst derivative
curve of the signal during the current peak. The peak
begins from location a; its maximum is at c and end
at e. Location b is for the maximum of the ﬁrst de-
rivative and d for its minimum. (For interpretation of
the references to colour in this ﬁgure legend, the
reader is referred to the Web version of this article.)
Fig. 3. The visualization of the peak variable values of disease and control (WT)
transient signals in two dimensions.
Table 1
Means and standard deviations of 12 variables for 5290 peaks of the disease transient signals and 2291 peaks of the control transient signals.
Variable number Peak variable Disease transient signal peaks Control transient signal peaks
1 Peak left side amplitude 201.3 ± 134.4 272.5 ± 170.2
2 Peak right side amplitude 203.4 ± 135.4 275.4 ± 171.8
3 Left duration [s] 0.31 ± 0.181 0.492 ± 0.263
4 Right duration [s] 0.597 ± 0.394 1.039 ± 0.601
5 Maximum of left side ﬁrst derivative 1348 ± 985 2131 ± 1276
6 Absolute minimum of right side ﬁrst derivative 780 ± 496.33 927 ± 635
7 Maximum of right side second derivative 3397 ± 3110 4465 ± 3386
8 Absolute minimum of right side second derivative 2116 ± 2561 3938 ± 4359
9 Peak area 68 ± 76 132 ± 115
10 Duration from peak maximum to preceding one (or beginning) [s] 1.039 ± 0.858 1.944 ± 1.58
11 Duration from peak beginning [s] to left side maximum of ﬁrst derivative 0.201 ± 0.14 0.312 ± 0.198
12 Duration from peak maximum [s] to right side minimum of ﬁrst derivative 0.138 ± 0.075 0.156 ± 0.145
Fig. 4. Medians of weights were calculated with the reliefF algorithm for the 12
variables of the current data by using 9 diﬀerent k values (number of nearest
neighbors). Variables 3, 4, 5 and 11 are the most eﬃcient and variables 9, 10
and 12 the least eﬃcient for the diﬀerentiation of the disease transient signals
from those of controls.
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weights were approximately equal as seen in Fig. 4. In any case, on the
basis of these results as well those in Table 1, all 12 variables were
found to be useful for the diﬀerentiation of disease and control calcium
transient signals from each other.
4. Classiﬁcation methods used and design of experiments
We used a wide collection of classiﬁcation algorithms in our study,
ranging from traditional methods to state-of-the-art methods. Since our
dataset consists of a true class label deﬁned by the human expert for
each signal, we concentrated only on supervised classiﬁcation methods
and, hence, semi-supervised and unsupervised methods were out of the
scope of this paper. Methods used in our study were mostly the same as
used in our previous study [23]. However, in Ref. [23] the classiﬁcation
task was multi-class by nature, whereas in this paper the classiﬁcation
task is a two-class problem. We do not present the detailed description
about the actual classiﬁcation methods, but a reader can ﬁnd thorough
descriptions about the algorithms from the given references. Compared
to Ref. [23], there were now two novel peak variables: variables 11 and
12 (Table 1).
As a ﬁrst classiﬁcation algorithm, we applied the k Nearest Neighbor
(kNN) searching method [24–26] that is one of the earliest classiﬁca-
tion algorithms and most used. The performance of the kNN algorithm
depends mainly on three factors: k value, distance measure, and dis-
tance weighting scheme. These factors are data-dependent and for each
dataset, a suitable combination must be searched separately. For our
study, we selected k values of 1, 5, 7, 11, 13 and 17 to be examined, and
here we followed the principle used in Ref. [23]. We selected eight
distance measures to be tested: Chebyshev, cityblock (Manhattan),
correlation, cosine, Euclidean, Mahalanobis, standardized Euclidean
and Spearman. We performed classiﬁcation with three distance
weighting schemes: no weighting (weighting equal to 1), reciprocal,
and squared reciprocal with respect to distance.
The second wholeness used was discriminant analysis based algo-
rithms. Discriminant analysis covers various variations, and from them
we applied linear discriminant analysis [27,28], quadratic discriminant
analysis [28,29], and Mahalanobis distance based discriminant analysis
[30]. When moving to probability based algorithms, naïve Bayes clas-
siﬁer [24,31,32] cannot be dismissed. Naïve Bayes is a classical widely
used method in many applications. It can be used with or without
kernel density estimation [24,31]. In this paper we used the naïve Bayes
algorithm in both senses. When kernel density estimation was used, we
examined Gaussian, box, triangle and Epanechnikov kernels. We also
applied the naïve Bayes classiﬁer without kernel density estimation
when the normal distribution assumption over the dataset is expected.
Besides naïve Bayes classiﬁer, kNN and discriminant analysis based
classiﬁcation methods, we used multinomial logistic regression [33,34]
which returns to logistic regression [31,32] in two-class tasks.
Decision tree-based solutions are commonly used alternatives in
machine learning tasks. Their advantages are easy interpretation and
computational eﬃciency. These issues are important to take into ac-
count when considering the end-users of our application, who are
persons not experts in the machine learning area. In our study, we in-
vestigated CART [25,35] algorithm and Random Forests [36–38]. For
Random Forests we varied the number of trees from 1 to 100.
The Support Vector Machine [39] has gained great popularity since
the early 1990s, and has been used in various applications. However, in
our study, we decided to use a variant of SVM called the least squares
support vector machine (LSSVM) [40–42] which diﬀers from traditional
SVM in such a way that LSSVM solves a system of linear equations
instead of a quadratic optimization problem. The performance of
LSSVM is heavily dependent on the selection of a kernel function and
(hyper)parameter values. Hence, it is always necessary to perform a
thorough search of (hyper)parameter values in order to ensure the best
possible result. A common parameter for all kernel functions in LSSVM
is C, also called box constraint. We selected the linear, quadratic, 3rd
degree of polynomial kernel and the RBF kernel to be examined in our
paper. The parameter value space for the box constraint and hy-
perparameter σ (the width of Gaussian function) is {2−12,2−11,
…,216,217}. By this means polynomial kernels were tested on 30
parameter values and the RBF kernel on 900 (C,σ) combinations.
The classiﬁcation was performed based on the leave-one-signal-out
(LOSO) procedure, which is a modiﬁcation compared to the leave-one-
out method. In signal classiﬁcation, a noticeable detail must be re-
membered. Variables are determined from peaks, and a signal consists
of one or more peaks. Thus, the data gained from one signal usually
includes several rows in an observation matrix. When deﬁning training
and test sets, one needs to ensure that the whole data from the signal is
in either the training or test set. Signal data must not be split into two,
such that one part is in training set and the other is in test set. In LOSO,
the peak-based data from each signal in turn forms a test set, and the
rest of the data are in the training set.
When we train a computational model based on a classiﬁcation
method, we must remember that the training phase of an algorithm is
performed on peak-based data, not on signal level data. Hence, a
classiﬁer learns its model based on peaks and not on signals. After
training of a classiﬁer, we give the test set as an input to the classiﬁer.
Then the classiﬁer gives a predicted class label for each peak in a test
set. In this stage, results are at peak level. However, since the aim of this
paper is signal classiﬁcation, we need to transform the peak level results
into a signal level result. This is done by taking a mode from the pre-
dicted class labels for peaks in a test set. We can do this because we use
the LOSO procedure, where a test set covers data only from one signal.
However, mode is not always unambiguously deﬁned and a tie may
occur. In our paper we had only two classes, so a tie could occur with
only two classes. If a tie occurred, we solved the problem in the fol-
lowing way.
1. Extract the training data of classes C1 and C2 occurring in a tie, from
the training set.
2. Find the proportions P1=(|C1|/(|C1|+|C2|))100% and P2=(|C2|/
(|C1|+|C2|))100% where |.| is the size of a set. Hence, an interval
[0,P1] is for the class C1 and interval (P1,100] is for the class C2.
3. Generate a random number R from the uniform distribution U(0,1).
4. If R*100% belongs to interval [0,P1], select C1 as ﬁnal class label for
the signal. Otherwise, select C2.
After ﬁnding a predicted class label for each signal in a dataset, we
can compare the predicted class label with the true label and construct
a confusion matrix. From the confusion matrix, we can evaluate dif-
ferent kinds of measures which describe how well the classiﬁcation has
succeeded. For our study, we selected accuracy ((TP + TN)/
(TP + TN + FN + FP)), true positive rate (TP/(TP + FN)) for diseases
and true negative rate (TN/(TN + FP)) for controls. For the classiﬁ-
cation methods which require parameter tuning, we repeated LOSO
with all parameter values examined, and selected a parameter value
(combination) that achieved the highest accuracy.
5. Classiﬁcation results of disease or control transient signals
The main target of the research was to study how eﬃciently two
transient signal groups can be diﬀerentiated from each other. For this
purpose, several classiﬁers were implemented as described above. Their
results are presented in the following.
Classiﬁcation results are shown in Tables 2–4, in which true positive
rates (sensitivity) correspond to disease transient signals, and true ne-
gative rates (speciﬁcity) to control signals. Accuracy equals the sum of
true positive and negative cases divided by the number of all cases.
Now k nearest neighbor searching with cityblock (Manhattan) metric
yielded the best accuracy results of 86.0% in Table 2. In Table 3, k
nearest neighbor searching with Euclidean metric and squared inverse
weighting was the best method, obtaining a 84.5% level. In Table 4, the
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support vector machine (LSSVM) with radial basis function (RBF)
kernel having an accuracy of 84.7% and random forest with 87.4%
were the best techniques. Overall, the classiﬁcation of data into two
classes was very successful.
6. Discussion
This study was aimed at investigating whether machine learning
could, in general, separate healthy cardiomyocytes from diseased ones.
The phenotype of the iPSC-derived CMs was determined by Ca2+
imaging. Both control and diseased cardiomyocytes contained cells
with normal beating, as well as those with abnormal beating behavior.
With machine learning, very high classiﬁcation accuracy values (up to
87.4%) were obtained to distinguish control and diseased cells, despite
both having mixed CM populations (containing both normal and ab-
normal CMs), i.e., to distinguish CMs derived from patients carrying a
mutation for a cardiac disease from control CMs.
The iPSC technology has revolutionized the study of genetic cardiac
diseases [43]. It enables the investigation of patient- and mutation-
speciﬁc cells in order to understand the disease pathophysiology of
interest, as well as to provide a platform to study drug responsiveness in
a personalized way [4]. However, CMs derived from iPSCs obtained
with current diﬀerentiation protocols still have several problems. They
are ﬁrst of all immature cardiomyocytes [44]. In addition, they present
all types of cardiomyocytes including atrial, ventricular and pacemaker
cells. These issues make it problematic to produce and determine a
disease phenotype in a reproducible way. In our current study, these
limitations were evident. The CMs were immature, and both our control
CMs as well as the diseased CMs were mixed cell populations and with
Ca2+ transient signals, e.g., ventricular or atrial cells cannot be dis-
tinguished from each other. However, despite these problems, our
machine learning procedure was successful to diﬀerentiate control CMs
from diseased CMs, suggesting the presence of characteristics of healthy
or diseased cells already in the fatal state and common for all types of
CMs.
Due to above mentioned problems with iPSC-derived CM, control
cells also included abnormal Ca2+ transients. In our study, 12.6% of
control cells presented various types of abnormalities. However, the
amount of abnormal transient signals was much greater (54.6%) in CMs
carrying any mutation for various genetic cardiac diseases including
genetic arrhythmias and cardiomyopathies. We demonstrated earlier
[23] that it is possible to diﬀerentiate genetic cardiac diseases from
each other based on machine learning techniques. In the current study,
the aim was to collect more transient signals of control CMs, to decrease
the diﬀerence between the smaller signal number of control CMS and
the greater signal number of diseased CMs compared to the earlier si-
tuation [23], and pool all diseased ones as one group, to analyze
whether this could be separated from control cells containing also both
abnormally and normally beating cells. Using diﬀerent algorithms and
methods for machine learning, we were able to produce paradigms with
high a classiﬁcation accuracy of up to 87.4%, suggesting that this
procedure could have potential use in clinical applications in the future.
7. Conclusions
Genetic cardiac diseases are clinically often problematic. First, the
disease phenotype is variable even within a single family [45]. Ad-
ditionally, it is still common despite advances in molecular genetics that
the mutation causing the disease in the family is not known. In this
situation, it is impossible to distinguish those who are potentially at risk
of developing the disease phenotype, which family members should be
regularly checked clinically, and who should be advised for lifestyle
restrictions or preventive medication. The results obtained in this study
are potentially promising to identify individuals at risk. iPSC-derived
CMs carrying a disease causing mutation can accurately be separated
from cells derived from healthy individuals, and thus potentially iPSC-
derived cardiomyocytes combined with machine learning algorithms
could in the future be used also clinically to identify individuals at risk,
Table 2
Classiﬁcation results of k nearest neighbor (kNN) searching, with diﬀerent metrics or measures with the best k value.
Classiﬁcation method True positive rates of diseases % True positive rates of controls % Accuracy %
kNN with Chebychev metric and equal weighting, k=1 87.3 69.3 81.3
kNN with Chebychev metric and inverse weighting, k=1 87.3 69.3 81.3
kNN with Chebychev metric and squared inverse weighting, k=5 86.5 71.4 81.5
kNN with cityblock metric and equal weighting, k=1 91.1 75.9 86.0
kNN with cityblock metric and inverse weighting, k=1 91.1 75.9 86.0
kNN with cityblock metric and squared inverse weighting, k=1 91.1 75.9 86.0
kNN with correlation measure and equal weighting, k=1 89.3 67.8 82.1
kNN with correlation measure and inverse weighting, k=5 89.3 71.4 83.3
kNN with correlation measure and squared inverse weighting, k=5 89.3 71.9 83.3
kNN with cosine measure and equal weighting, k=1 86.8 71.4 81.6
kNN with cosine measure and inverse weighting, k=5 87.8 74.4 83.3
kNN with cosine measure and squared inverse weighting, k=7 89.3 72.9 83.8
Table 3
More classiﬁcation results of k nearest neighbor (kNN) searching, with diﬀerent metrics or measures with the best k value.
Classiﬁcation method True positive rates of diseases % True negative rates of controls % Accuracy %
kNN with Euclidean metric and equal weighting, k=1 89.1 74.4 83.8
kNN with Euclidean metric and inverse weighting, k=1 89.1 74.4 84.1
kNN with Euclidean metric and squared inverse weighting, k=5 90.1 73.4 84.5
kNN with Mahalanobis metric and equal weighting, k=1 90.9 71.4 84.3
kNN with Mahalanobis metric and inverse weighting, k=1 90.9 71.4 84.3
kNN with Mahalanobis metric and squared inverse weighting, k=1 90.9 71.4 84.3
kNN with standardized Euclidean metric and equal weighting. k=1 89.1 74.4 84.1
kNN with standardized Euclidean metric and inverse weighting, k=1 89.1 74.4 84.1
kNN with standardized Euclidean metric and squared inverse weighting, k=5 89.8 73.4 84.3
kNN with Spearman measure and equal weighting, k=1 88.6 66.3 81.1
kNN with Spearman measure and inverse weighting, k=5 89.6 69.3 82.8
kNN with Spearman measure and squared inverse weighting, k=5 90.4 69.3 83.3
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and make it possible to focus preventive actions on those, and relieve
the disease burden from those without any signs of disease at the cel-
lular level.
The high accuracy obtained with our best machine learning algo-
rithm suggests that iPSC technology combined with machine learning
could be used even for diagnostic purposes in the future. We will
continue to collect more Ca2+ transient signals of CMs derived from a
larger collection of iPS cell lines carrying diﬀerent mutations and pa-
tient populations, as well as signals of healthy controls, and also from
isogenic lines, and thus to improve these methods to make them more
suitable for clinical purposes.
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